A Case of Identity: <i>HOX</i> Genes in Normal and Cancer Stem Cells

Stem cells are undifferentiated cells that have the unique ability to self-renew and differentiate into many different cell types. Their function is controlled by core gene networks whose misregulation can result in aberrant stem cell function and defects of regeneration or neoplasia. <i>HOX&l...

Full description

Bibliographic Details
Main Authors: Jessica Smith, Ahmad Zyoud, Cinzia Allegrucci
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/11/4/512
_version_ 1797706635558256640
author Jessica Smith
Ahmad Zyoud
Cinzia Allegrucci
author_facet Jessica Smith
Ahmad Zyoud
Cinzia Allegrucci
author_sort Jessica Smith
collection DOAJ
description Stem cells are undifferentiated cells that have the unique ability to self-renew and differentiate into many different cell types. Their function is controlled by core gene networks whose misregulation can result in aberrant stem cell function and defects of regeneration or neoplasia. <i>HOX</i> genes are master regulators of cell identity and cell fate during embryonic development. They play a crucial role in embryonic stem cell differentiation into specific lineages and their expression is maintained in adult stem cells along differentiation hierarchies. Aberrant <i>HOX</i> gene expression is found in several cancers where they can function as either oncogenes by sustaining cell proliferation or tumor-suppressor genes by controlling cell differentiation. Emerging evidence shows that abnormal expression of <i>HOX</i> genes is involved in the transformation of adult stem cells into cancer stem cells. Cancer stem cells have been identified in most malignancies and proved to be responsible for cancer initiation, recurrence, and metastasis. In this review, we consider the role of <i>HOX</i> genes in normal and cancer stem cells and discuss how the modulation of <i>HOX</i> gene function could lead to the development of novel therapeutic strategies that target cancer stem cells to halt tumor initiation, progression, and resistance to treatment.
first_indexed 2024-03-12T05:54:14Z
format Article
id doaj.art-28454e976ece4833bf73528a48950110
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T05:54:14Z
publishDate 2019-04-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-28454e976ece4833bf73528a489501102023-09-03T04:43:59ZengMDPI AGCancers2072-66942019-04-0111451210.3390/cancers11040512cancers11040512A Case of Identity: <i>HOX</i> Genes in Normal and Cancer Stem CellsJessica Smith0Ahmad Zyoud1Cinzia Allegrucci2SVMS, Faculty of Medicine and Health Sciences, University of Nottingham, Sutton Bonington Campus, Loughborough LE12 5RD, UKSVMS, Faculty of Medicine and Health Sciences, University of Nottingham, Sutton Bonington Campus, Loughborough LE12 5RD, UKSVMS, Faculty of Medicine and Health Sciences, University of Nottingham, Sutton Bonington Campus, Loughborough LE12 5RD, UKStem cells are undifferentiated cells that have the unique ability to self-renew and differentiate into many different cell types. Their function is controlled by core gene networks whose misregulation can result in aberrant stem cell function and defects of regeneration or neoplasia. <i>HOX</i> genes are master regulators of cell identity and cell fate during embryonic development. They play a crucial role in embryonic stem cell differentiation into specific lineages and their expression is maintained in adult stem cells along differentiation hierarchies. Aberrant <i>HOX</i> gene expression is found in several cancers where they can function as either oncogenes by sustaining cell proliferation or tumor-suppressor genes by controlling cell differentiation. Emerging evidence shows that abnormal expression of <i>HOX</i> genes is involved in the transformation of adult stem cells into cancer stem cells. Cancer stem cells have been identified in most malignancies and proved to be responsible for cancer initiation, recurrence, and metastasis. In this review, we consider the role of <i>HOX</i> genes in normal and cancer stem cells and discuss how the modulation of <i>HOX</i> gene function could lead to the development of novel therapeutic strategies that target cancer stem cells to halt tumor initiation, progression, and resistance to treatment.https://www.mdpi.com/2072-6694/11/4/512<i>HOX</i> genesstem cellscancer stem cellsself-renewaldifferentiationtargeted therapy
spellingShingle Jessica Smith
Ahmad Zyoud
Cinzia Allegrucci
A Case of Identity: <i>HOX</i> Genes in Normal and Cancer Stem Cells
Cancers
<i>HOX</i> genes
stem cells
cancer stem cells
self-renewal
differentiation
targeted therapy
title A Case of Identity: <i>HOX</i> Genes in Normal and Cancer Stem Cells
title_full A Case of Identity: <i>HOX</i> Genes in Normal and Cancer Stem Cells
title_fullStr A Case of Identity: <i>HOX</i> Genes in Normal and Cancer Stem Cells
title_full_unstemmed A Case of Identity: <i>HOX</i> Genes in Normal and Cancer Stem Cells
title_short A Case of Identity: <i>HOX</i> Genes in Normal and Cancer Stem Cells
title_sort case of identity i hox i genes in normal and cancer stem cells
topic <i>HOX</i> genes
stem cells
cancer stem cells
self-renewal
differentiation
targeted therapy
url https://www.mdpi.com/2072-6694/11/4/512
work_keys_str_mv AT jessicasmith acaseofidentityihoxigenesinnormalandcancerstemcells
AT ahmadzyoud acaseofidentityihoxigenesinnormalandcancerstemcells
AT cinziaallegrucci acaseofidentityihoxigenesinnormalandcancerstemcells
AT jessicasmith caseofidentityihoxigenesinnormalandcancerstemcells
AT ahmadzyoud caseofidentityihoxigenesinnormalandcancerstemcells
AT cinziaallegrucci caseofidentityihoxigenesinnormalandcancerstemcells